We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial.
- Authors
Yardley, Denise A; Brufsky, Adam; Coleman, Robert E; Conte, Pierfranco F; Cortes, Javier; Glück, Stefan; Nabholtz, Jean-Mark A; O'Shaughnessy, Joyce; Beck, Robert M; Ko, Amy; Renschler, Markus F; Barton, Debora; Harbeck, Nadia
- Abstract
A correction to the article "Phase I/III Weekly Nab-Paclitaxel Plus Gemcitabine or Carboplatin Versus Gemcitabine/Carboplatin As First-Line Treatment of Patients With Metastatic Triple-Negative Breast Cancer (the tnAcity Study): Study Protocol for a Randomized Controlled Trial" by Denise A. Yardley et al. that was published in a 2015 issue is presented.
- Subjects
BREAST cancer treatment; PACLITAXEL; CARBOPLATIN; THERAPEUTICS
- Publication
Trials, 2016, Vol 17, p1
- ISSN
1745-6215
- Publication type
corrected article
- DOI
10.1186/s13063-016-1195-6